199
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Prognostic features of patients with myelodysplastic syndromes aged < 50 years: update of a single-institution experience

, , , , , , , , , & show all
Pages 2439-2443 | Received 19 Apr 2012, Accepted 26 May 2012, Published online: 09 Jul 2012

References

  • Konrokji RS, Zhang L, Bennett JM.Myelodysplastic syndromes classification and risk stratification.Hematol Oncol Clin North Am2010;24:443–457.
  • Germing U, Strupp C, Kungden A, .No increase in age-specific incidence of myelodysplastic syndromes.Haematologica2004;89:905–910.
  • Fenaux P, Preudhomme C, Helene Estienne M, .De novo myelodysplastic syndromes in adults aged 50 or less. A report on 37 cases.Leuk Res1990;14:1053–1059.
  • Chang KL, O’Donnell MR, Slovak ML, .Primary myelodysplasia occurring in adults under 50 years old: a clinicopathologic study of 52 patients.Leukemia2002;16:623–631.
  • Kuendgen A, Strupp C, Aivado M, .Myelodysplastic syndromes in patients younger than age 50.J Clin Oncol2006;34:5358–5365.
  • Breccia M, Mengarelli A, Mancini M, .Myelodysplastic syndromes in patients under 50 years old: a single institution experience.Leuk Res2005;29:749–754.
  • Bennett JM, Catovsky D, Daniel MT, .Proposals for the classification of the myelodysplastic syndromes.Br J Haematol1982;51:189–199.
  • Vardiman JW, Thiele J, Arber DA, .The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.Blood2009;114:937–951.
  • Greenberg P, Cox C, LeBeau MM, .International scoring system for evaluating prognosis in myelodysplastic syndrome.Blood1997;89:2079–2088.
  • Malcovati L, Germing U, Kuendgen A, .Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndrome.J Clin Oncol2007;25:3503–3510.
  • Kantarjian H, O’Brien S, Ravandi F, .Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.Cancer2008;113:1351–1356.
  • Gologan R.Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania.Leuk Res2010;34:1442–1446.
  • Chen B, Zhao WL, Jin J, .Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries.Leukemia2005;19:767–775.
  • Oguma S, Yoshida Y, Uchino H, .Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a cooperative study based on 838 cases.Leuk Res1995;19:219–225.
  • Matsuda A, Germing U, Jinnai I, .Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes.Blood2005;106:2633–2640.
  • Lau LG, Chng WJ, Liu TC, .Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and International prognostic scoring system.Ann Acad Med Singapore2004;33:589–595.
  • Paydas S.Young age MDS: differences between Western and Eastern countries.Leuk Res2006;30:362.
  • Alessandrino EP, Amadori S, Barosi G, .Evidence and consensus based practice guidelines for the therapy of primary myelodysplastic syndromes.A statement from the Italian Society of Hematology. Haematologica2002;87:1286–1306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.